Ampullary adenocarcinoma: Defining predictors of survival and the impact of adjuvant therapy following surgical resection for stage I disease.

Zachary E StilesStephen W BehrmanJeremiah L DeneveEvan S GlazerLei DongJim Y WanMichael G MartinPaxton V Dickson

Published in: Journal of surgical oncology (2018)

This analysis revealed a modest 5-year OS for stage I AAC. Age, positive resection margins, and evaluation of <12 LNs negatively influenced OS and AT did not convey a survival benefit.

Keyphrases

free survival
squamous cell carcinoma
single cell
radiation therapy
data analysis